MPM Asset Management LLC
- SEC CIK
- 0001263048
- Latest filing
- Nov 14, 2025
Holdings in Q2 2023
Holdings as of Jun 30, 2023, filed Sep 7, 2023. Long positions only; changes compare share counts with Q1 2023.
- Positions
- 8
- −1 vs. Q1 2023
- Portfolio value
- $203.9M
- −$36.1M (−15.0%) vs. Q1 2023
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| TRDAEntrada Therapeutics, Inc. | COM | 4,425,784 | $67.0M | 32.9% | 00.0% | Unchanged | History |
| DYNDyne Therapeutics, Inc. | COM | 4,951,303 | $55.7M | 27.3% | 00.0% | Unchanged | History |
| ITOSiTeos Therapeutics, Inc. | COM | 2,738,785 | $36.3M | 17.8% | 00.0% | Unchanged | History |
| RPTXRepare Therapeutics Inc. | COM | 2,242,636 | $23.7M | 11.6% | 00.0% | Unchanged | History |
| HOWLWerewolf Therapeutics, Inc. | COM | 4,284,172 | $13.1M | 6.4% | 00.0% | Unchanged | History |
| ADAPYAdaptimmune Therapeutics PLC | SPONDS ADR | 6,287,101 | $5.82M | 2.9% | +6,287,101 | New | History |
| HARPHarpoon Therapeutics, Inc. | COM | 3,131,388 | $2.22M | 1.1% | 00.0% | Unchanged | History |
| ONCROncorus, Inc. | COM | 2,849,464 | $115.4K | 0.1% | 00.0% | Unchanged | History |
Sold out since Q1 2023 (2)
Positions held at the end of Q1 2023 that are gone from this filing.